241 related articles for article (PubMed ID: 27890239)
1. Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma.
Santana AL; Felsen D; Carucci JA
Dermatol Clin; 2017 Jan; 35(1):73-84. PubMed ID: 27890239
[TBL] [Abstract][Full Text] [Related]
2. Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
Strobel SB; Safferling K; Lahrmann B; Hoffmann JH; Enk AH; Hadaschik EN; Grabe N; Lonsdorf AS
Br J Dermatol; 2018 Aug; 179(2):405-412. PubMed ID: 29479687
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22.
Abikhair M; Mitsui H; Yanofsky V; Roudiani N; Ovits C; Bryan T; Oberyszyn TM; Tober KL; Gonzalez J; Krueger JG; Felsen D; Carucci JA
JCI Insight; 2016 Jun; 1(8):e86434. PubMed ID: 27699266
[TBL] [Abstract][Full Text] [Related]
5. Nonmelanoma Skin Cancers After Kidney Transplant: Our 15 Years of Experience With Mammalian Target of Rapamycin Inhibitors.
Okut G; Alp A; Tatar E; Simsek C; Tugmen C; Uslu A
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):236-239. PubMed ID: 28260475
[TBL] [Abstract][Full Text] [Related]
6. Myocardial metastasis of cutaneous squamous cell carcinoma in a renal transplant recipient.
Mackenzie KA; Simcock JW; Lainchbury JG; Currie MJ; Lynn KL
Transplant Proc; 2009 Dec; 41(10):4414-5. PubMed ID: 20005411
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Vidovic D; Simms GA; Pasternak S; Walsh M; Peltekian K; Stein J; Helyer LK; Giacomantonio CA
Front Immunol; 2021; 12():678028. PubMed ID: 34122442
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U
J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198
[TBL] [Abstract][Full Text] [Related]
10. Skin cancer in liver transplant recipients.
Otley CC; Pittelkow MR
Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
12. Conjunctival epithelial neoplasias in organ transplant patients receiving cyclosporine therapy.
Macarez R; Bossis S; Robinet A; Le Callonnec A; Charlin JF; Colin J
Cornea; 1999 Jul; 18(4):495-7. PubMed ID: 10422866
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.
Herman S; Rogers HD; Ratner D
Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101
[TBL] [Abstract][Full Text] [Related]
14. Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.
Zhang S; Fujita H; Mitsui H; Yanofsky VR; Fuentes-Duculan J; Pettersen JS; Suárez-Fariñas M; Gonzalez J; Wang CQ; Krueger JG; Felsen D; Carucci JA
PLoS One; 2013; 8(5):e62154. PubMed ID: 23667456
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of p38 and Akt signaling pathways abrogates cyclosporine A-mediated pathogenesis of aggressive skin SCCs.
Arumugam A; Walsh SB; Xu J; Afaq F; Elmets CA; Athar M
Biochem Biophys Res Commun; 2012 Aug; 425(2):177-81. PubMed ID: 22820192
[TBL] [Abstract][Full Text] [Related]
16. Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma.
Abikhair Burgo M; Roudiani N; Chen J; Santana AL; Doudican N; Proby C; Felsen D; Carucci JA
JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185657
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC.
Plasmeijer EI; Sachse MM; Gebhardt C; Geusau A; Bouwes Bavinck JN
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():33-37. PubMed ID: 31833604
[TBL] [Abstract][Full Text] [Related]
18. Immune phenotype of peripheral blood cells and skin squamous cell carcinoma in organ transplant recipients.
Dziunycz P; Hofbauer GF
Expert Rev Clin Immunol; 2010 May; 6(3):359-62. PubMed ID: 20441422
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment.
Kim C; Cheng J; Colegio OR
Semin Oncol; 2016 Jun; 43(3):390-4. PubMed ID: 27178693
[TBL] [Abstract][Full Text] [Related]
20. Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient receiving treatment with everolimus.
Gambichler T; Hessam S; Lüttringhaus T; Boms S
Clin Exp Dermatol; 2022 Mar; 47(3):608-609. PubMed ID: 34767651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]